Connect with us

Technology

Medical Oxygen Concentrators Market to Reach USD 7.1 Billion by 2034, Growing at a 6.9% CAGR: Surge in Demand for Sustainable and Cost-Effective Solutions Drives Market Growth | TMR

Published

on

According to the latest medical oxygen concentrators market trends, Asia Pacific held largest share in 2023. Rise in prevalence of hospital-based pneumonia is fueling the market dynamics of the region.

WILMINGTON, Del., July 26, 2024 /PRNewswire/ — The global medical oxygen concentrators market was projected to attain US$ 3.4 billion in 2023. It is anticipated to garner a 6.9% CAGR from 2024 to 2034, and by 2034, the market is likely to attain US$ 7.1 billion.

The medical oxygen concentrator is one form of medical equipment used to provide oxygen to people with breathing-related illnesses. The respiratory mechanisms and metabolism of living things depend heavily on oxygen. An oxygen concentrator is frequently necessary for those with low blood oxygen concentrations to restore oxygen levels.

Oxygen concentrators use pressure swing adsorption to provide concentrated oxygen up to 95.5%. Using these concentrators to administer oxygen treatment is a practical and economical approach. An electronic user interface that helps with modifying the oxygen concentration levels and delivery parameters is included with medical oxygen concentrators.

Download Sample PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3998 

Medical oxygen concentrators are medical devices that are used to segregate nitrogen from air in order to extract pure oxygen. The oxygen concentrated using these devices can be up to 95% pure. The device draws air in, passes it through a filter, and then compresses it. The filters take up nitrogen and let oxygen to pass through, collecting it in a tank. Thereafter, the compressed oxygen is delivered through a facemask or open prongs beneath the nostrils via a tiny tube that extends from the device.

Portable oxygen concentrators are also available that run on rechargeable battery and are mostly equipped to supply oxygen by pulse dose, wherein tiny bursts of oxygen get released during each breathe. It is important to note that oxygen concentrators require constant power supply to operate. Medical oxygen concentrators are prescribed to patients suffering from chronic obstructive pulmonary disease (COPD), asthma, emphysema, cystic fibrosis, among others. Additionally, in high altitude locations, athletes also require oxygen concentrators in order to reduce fatigue and enhance training.

It is worth noting that in the U.S. alone, annually more than 1.5 million individuals require supplemental oxygen therapy. Further, as per estimates from the UNICEF, in low- and middle-income countries (LMICs), over 7 million children suffer from severe pneumonia every year. The rising levels of air pollution also contribute to the surging burden of respiratory diseases. The World Health Organization reports that almost the entire global population is exposed to polluted air, with LMICs suffering from highest exposures. The aforementioned factors are cumulatively leading to an increased demand for oxygen therapy. Specifically, during COVID-19 pandemic, the demand for oxygen concentrators skyrocketed as infected patients required long term oxygen therapy. The WHO estimated that 20-40% of mortality due to pneumonia, during the COVID-19 pandemic were preventable with sufficient oxygen supply. However, the recent years have witnessed numerous advancements in medical oxygen concentrator technology with the advent of precise oxygen delivery mechanisms.

Modern oxygen concentrators utilize pulse flow mechanism that dynamically accommodate to evolving requirements of the patient. In the future, oxygen concentrators are anticipated to be smaller and carried in a pocket or worn on a belt, offering respiratory care patients with enhanced mobility. Compact compressors and more efficient batteries would also allow for compact oxygen concentrators, as technology advances. With the integration of artificial intelligence and machine learning, oxygen concentrators can precisely analyze breathing patterns and modify oxygen delivery. The advent of this breakthrough technology is poised to eliminate uncertainties and result in personalized therapy regimens.

Key Findings of Market Report

Blood oxygen levels below normal constitute the medical condition known as hypoxemia.Medicinal oxygen concentrators are a useful tool for treating hypoxemia.These concentrators are a good and appropriate choice for providing oxygen at the point of care.A research published in the Lancet Global Health in 2022 found that the prevalence of hypoxemia was 31% among all children with WHO-classified pneumonia, 41% among those with very severe or severe pneumonia, and 8% among those with non-severe pneumonia.Therefore, the market demand for medical oxygen concentrators is being driven by the high frequency of hypoxemia among children who have severe pneumonia.

Market Trends for Medical Oxygen Concentrators

Refilling medical oxygen concentrators is not necessary. These concentrators provide 90% to 95% pure oxygen by continually purifying ambient air. They provide infinite oxygen and are powered by electricity. When compared to compressed gas cylinders, these concentrators are more economical.Batteries and other accessories have an impact on the cost of new home oxygen concentrators. Even less expensive are used oxygen concentrators, depending on the model, hours, and guarantee. In order to reduce the cost of concentrators, certain businesses in the medical oxygen concentrator sector are providing rental services and reconditioned oxygen concentrators.One of the primary factors preventing the medical oxygen concentrator market from growing is the lack of proper maintenance, training, equipment selection, and acquisition in developing nations.

Medical Oxygen Concentrators Market Report Scope:

Report Coverage

Details 

Forecast Period  

2024-2034

Base Year  

2020-2022

Size in 2023

US$ 3.4 Bn

Forecast (Value) in 2034

US$ 7.1 Bn

Growth Rate (CAGR) 

6.9 %

No. of Pages 

171 Pages 

Segments covered 

By Modality, By Technology, By End-user, By Region

Global Market for Medical Oxygen Concentrators: Regional Outlook

Asia Pacific accounted for the highest proportion in 2023. The region’s market dynamics are being driven by an increase in the prevalence of hospital-based pneumonia.Pneumonia in children is a serious clinical and public health concern. About 20% of all pediatric fatalities worldwide include pneumonia, with the majority of those deaths occurring in India.The market share of medical oxygen concentrators in Asia Pacific is also increasing due to the high frequency of respiratory illnesses. China accounted for 24% of all new diagnoses, 21% of all prevalent cases, 32% of all deaths, and 27% of all DALYs from chronic obstructive pulmonary disease globally in 2019, according to estimates from the Global Burden of Disease Study.

Request Table of Content Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=3998 

Global Medical Oxygen Concentrators Market: Competitive Landscape

In order to further improve goods and maintain their competitiveness in the market, significant companies competing in the landscape are employing direct patient input in their research and development activities.

Additionally, they provide portable electronics that are perfect for usage in homes, workplaces, and transit. The following companies are well-known participants in the global medical oxygen concentrators market:

Chart Industries Inc.Inogen Inc.Invacare CorporationKoninklijke Philips N.V.ResMed Inc.Drive DeVilbiss HealthcarePrecision Medical, Inc.Besco Medical Co., Ltd.02 Concepts, LLCGCE Group

Some key developments by the players in this market are:

In order to better service its clients in the Asia Pacific area, the oxygen supply producer CAIRE opened a brand-new, innovative medical technology center in Chengdu, China, in March 2024. Along with a variety of specific AirSep commercial oxygen concentrators, the facility will produce the Eclipse 5 portable oxygen concentrator and the VisionAire 5 stationary oxygen concentrator for the firm.O2 Concepts declared in January 2024 that the Oxlife LIBERTY, their most cutting-edge proof of concept device, now has greater continuous flow capabilities. The Oxlife LIBERTY is equipped with the business’s unique DNA Technology, an intelligent cellular technology that is launched by the device and links DMEs to device data to enable unprecedented levels of inventory control, asset management, and operating efficiency.

Global Medical Oxygen Concentrators Market Segmentation 

By Modality

PortableStationary

By Technology

Pulse FlowContinuous Flow

By End User

HospitalsHome CareAmbulatory Surgical Centers

By Region

North AmericaLatin AmericaEuropeAsia PacificMiddle East & Africa

Purchase the Report for Market-Driven Insights: https://www.transparencymarketresearch.com/checkout.php?rep_id=3998&ltype=S 

Have a Look at More Valuable Insights of Healthcare

Stethoscope Market: The global stethoscope market is likely to expand at a CAGR of 5.5% from 2022 to 2032. People today are more willing to opt for physical examinations and undertake diagnoses with the inclination toward health and fitness.Hybrid Operating Room Market: The global Hybrid Operating Room Market is expected to grow at a CAGR of 7.7% from 2022 to 2031.Oxidative Stress Assays Market is expected to grow at a CAGR of 9.4% from 2024 to 2034 and reach US$ 2.8 Bn by the end of 2034

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/medical-oxygen-concentrators-market-to-reach-usd-7-1-billion-by-2034–growing-at-a-6-9-cagr-surge-in-demand-for-sustainable-and-cost-effective-solutions-drives-market-growth–tmr-302207457.html

SOURCE Transparency Market Research

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

HydraForce, Elevāt, and Bosch Rexroth Announce Enhanced Remote OTA Update Capabilities for Off-Highway Equipment

Published

on

By

SEATTLE, July 23, 2026 /PRNewswire/ — Building on their strategic collaboration, HydraForce, a global leader in motion control systems and Elevāt, an industrial IoT and applied AI platform provider, announced a significant advancement in remote machine management.

The HydraForce Connected Control Unit (CCU) from Bosch, integrated with Elevāt software, is now capable of providing remote access and performing over-the-air (OTA) updates on Bosch Rexroth BODAS controllers.

This enhanced capability empowers HydraForce and Elevāt customers to streamline operations, reduce downtime, and significantly improve machine performance and serviceability. By leveraging the integrated solution, OEMs can use the Elevāt platform to remotely diagnose issues and deploy critical software updates to the BODAS controllers on their equipment without requiring on-site service personnel.

“The ability to remotely access and update Bosch Rexroth BODAS controllers using the Elevāt platform takes our collaborative vision of bridging hydraulics, electronics, and digital services to the next level,” said Russ Schneidewind, director of business developmentat at HydraForce.  “The cooperation between Elevāt and Bosch Rexroth is directly addressing the industry’s need for complete, future-ready solutions.”

Adam Livesay, co-founder and CEO of Elevāt, commented, “At Elevāt, we believe the future of equipment service is connected, intelligent, and proactive. This collaboration helps OEMs deliver the next generation of service by  accelerating software deployment and enabling faster issue resolution in the field. The addition of remote BODAS controller updates is another key milestone toward a fully integrated ecosystem that simplifies the connection between hardware, software, and digital services—helping manufacturers bring intelligent equipment to market faster while creating new opportunities for recurring customer value.”

HydraForce and Elevāt plan to further their collaboration with additional remote machine management capabilities to be announced in the future.

About HydraForce HydraForce is a global designer and manufacturer of motion control systems, encompassing hydraulic cartridge valves, manifolds and electronic controls for a variety of off-highway industries, including farming, construction, marine, material handling, mining, and forestry. HydraForce was acquired by Bosch Rexroth, becoming a significant part of the Compact Hydraulics Business Unit. Bosch Rexroth and HydraForce combine their presence in complementary regions to provide comprehensive coverage in Europe and North America, while enabling growth in Asia.

About Bosch Rexroth As one of the world’s leading suppliers of drive and control technologies, Bosch Rexroth ensures efficient, powerful and safe movement in machines and systems of any size. The company bundles global application experience in the market segments of Mobile and Industrial Applications as well as Factory Automation. With its intelligent components, customized system solutions, engineering and services, Bosch Rexroth is creating the necessary environment for fully connected applications. Bosch Rexroth offers its customers hydraulics, electric drive and control technology, gear technology and linear motion and assembly technology, including software and interfaces to the Internet of Things. With locations in over 80 countries, around 31,900 associates generated sales revenue of 6.5 billion euros in 2025.  To learn more, please visit www.boschrexroth.com.

About Bosch Having established a presence in North America in 1906, today the Bosch Group employs around 38,000 associates in more than 100 locations in the North American region (as of Dec. 31, 2024). According to preliminary figures, Bosch generated consolidated sales of $18.7 billion in the U.S., Mexico and Canada in 2025. For more information visit www.bosch.us, www.bosch.mx and www.bosch.ca. The Bosch Group is a leading global supplier of technology and services. It employs roughly 412,000 associates worldwide (as of December 31, 2025). According to preliminary figures, the company generated sales of 91 billion euros in 2025. Its operations are divided into four business sectors: Mobility, Industrial Technology, Consumer Goods, and Energy and Building Technology. With its business activities, the company aims to use technology to help shape universal trends such as automation, electrification, digitalization, connectivity, and an orientation to sustainability. In this context, Bosch’s broad diversification across regions and industries strengthens its innovativeness and robustness. Bosch uses its proven expertise in sensor technology, software, and services to offer customers cross-domain solutions from a single source. It also applies its expertise in connectivity and artificial intelligence in order to develop and manufacture user-friendly, sustainable products. With technology that is “Invented for life,” Bosch wants to help improve quality of life and conserve natural resources. The Bosch Group comprises Robert Bosch GmbH and its roughly 490 subsidiary and regional companies in over 60 countries. Including sales and service partners, Bosch’s global manufacturing, engineering, and sales network covers nearly every country in the world. Bosch’s innovative strength is key to the company’s further development. At 136 locations across the globe, Bosch employs some 82,000 associates in research and development. The company was set up in Stuttgart in 1886 by Robert Bosch (1861-1942) as “Workshop for Precision Mechanics and Electrical Engineering.” The special ownership structure of Robert Bosch GmbH guarantees the entrepreneurial freedom of the Bosch Group, making it possible for the company to plan over the long term and to undertake significant upfront investments in the safeguarding of its future. Ninety-four percent of the share capital of Robert Bosch GmbH is held by Robert Bosch Stiftung GmbH, a limited liability company with a charitable purpose. The remaining shares are held by Robert Bosch GmbH and by a company owned by the Bosch family. The majority of voting rights are held by Robert Bosch Industrietreuhand KG. It is entrusted with the task of safeguarding the company’s long-term existence and in particular its financial independence – in line with the mission handed down in the will of the company’s founder, Robert Bosch. Additional information is available online at www.bosch-press.com, www.bosch.com.

About Elevāt Elevāt is a leading industrial IoT and applied AI platform purpose-built for off-highway OEMs. Elevāt enables manufacturers to connect machines, unlock actionable intelligence, and deliver next-generation digital services across the entire equipment lifecycle. Additional information is available online at www.getelevat.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/hydraforce-elevt-and-bosch-rexroth-announce-enhanced-remote-ota-update-capabilities-for-off-highway-equipment-302833060.html

SOURCE Elevat, Inc

Continue Reading

Technology

FutureSports launches as new index provider transforming sports statistics into tradable financial instruments

Published

on

By

Backed by leading financial and sports institutions, firm will leverage partnerships to bring critical new hedging vehicles to sports ecosystem

CHICAGO, July 23, 2026 /PRNewswire/ — FutureSports, the new independent index administrator transforming professional and college sports statistics into rules-based, benchmark financial indexes, today announced its emergence from stealth. Backed by a broad range of leading financial and sports institutions, FutureSports in the coming months will announce a series of partnerships, collaborations and products that will bring significant new risk management and trading opportunities to the massive ecosystem supporting the most popular sports.

FutureSports previously raised a seed investment round co-led by Marquee Ventures, spun out of the ownership group of the Chicago Cubs. Major financial industry leaders joined the round, including CME Ventures (the corporate venture capital division of CME Group), Robinhood Markets, Inc., WEDBUSH and DRW Special Investments (an investment arm of DRW). Other investors include Motivate VC, Phoenix Capital Ventures, and John and Linda Henry (Fenway Sports Group).

The company also announced the addition of industry experts to its board of directors, including Chairman Mark Wassersug, longtime Chief Operating & Information Officer of Intercontinental Exchange (ICE); Tim McCourt, Senior Managing Director, Global Head of Equity, FX, and Alternative Products at CME Group, and Erik Hammer, Managing Partner at Marquee Ventures.

The firm will soon unveil its first series of exclusive partnerships with major sports leagues, paving the way for institutional investors and companies in and around the sports industry to manage their risk in an unprecedented fashion and participate in regulated, tradable, broad-based index futures contracts based on team and athlete statistical performance. FutureSports creates rules-based financial indexes, known as FutureSports Performance Indexes (FSPI), that accurately represent the performance of teams and athletes in prominent sports leagues. By utilizing transparent, rules-based methodologies based on officially reported statistical outcomes, the company creates continuous values designed to underpin tradable financial products, such as listed derivatives, exchange-traded funds (ETFs) and over-the-counter (OTC) swaps.

Potential market participants will include league broadcasting partners, team and athlete sponsors and endorsers, insurers, stadium owners and operators, private equity investors, lenders, and apparel manufacturers. Asset managers, pension funds and professional trading firms are expected to participate in the contracts and contribute to liquidity in this new uncorrelated asset class. Retail investors will also be able to participate in the first-of-their-kind trading vehicles, which the company expects to capture the interest of sophisticated traders looking for more traditional financial trading instruments

Leigh Taylforth, FutureSports Co-Founder, said: “The global sporting industry generates $650 billion a year, yet there has been no liquid, robust opportunity to hedge the extensive and varied industry risks that range from weather events, to injuries, to unanticipated behavior issues and more. That is about to change. We’ve been truly gratified to see the interest our business has generated within the sports and sports-adjacent industries and the quality of investors we have attracted already.”

Rhett Dinsdale, FutureSports Co-Founder, said: “Up until today, we have been operating in stealth mode while developing our products and establishing key relationships that we expect to be fundamental to our success as we move forward. The recent rise in popularity of prediction markets has only reinforced the concept we created several years ago, that sports as an asset class has huge utility within the sports and entertainment industries, with indexes serving as key institutional instruments to manage risk. What is sorely needed is the type of reliable data and financial instruments that institutional investors have leveraged for so long within the regulated derivatives industry, and we’re excited to bring these to market.”

The Executive team includes Co-Founders Taylforth and Dinsdale, who each have more than 20 years of experience in derivatives trading for market makers, investment banks and hedge funds, along with:

Dave Abbott, Chief Technology Officer – formerly Managing Director at Sportradar;Steve Byrd, Head of Partnerships – formerly Chief Operating Officer (COO) at STATS LLC & Chief Commercial Officer at Sportradar US;Jodie Gunzberg, Head of Index Services – formerly Managing Director at S&P Dow Jones Indices, Morgan Stanley & CoinDesk;Tom Jenkins, Head of Business Development – formerly Head of Index Partnerships & Strategy at FTSE Russell;Josh Kravitt, Head of Operations – formerly Director at CME Ventures;Sunny Modi, Head of Product – formerly Head of BI at Ardent Leisure Group;Mike Philipp, Chief Legal & Strategy Officer – formerly partner at Morgan, Lewis & Bockius LLP;Charlie Thornton, Chief Regulatory Affairs Officer – formerly Chief of Staff and COO at the U.S. Commodity Futures Trading Commission (CFTC).

About FutureSports

Under development since 2022 and launched in 2026, Chicago-based FutureSports has created a proprietary index methodology for measuring on-field, on-ice and on-court performance for a range of professional sporting teams and athletes. Partnering with many of the most recognizable sports leagues and financial market participants, FutureSports transforms live, play-by-play statistical data into rules-based, benchmark indexes that may be referenced by exchange-listed financial products. The indexes are designed to serve the same benchmarking function as the leading equity, commodity and fixed income indexes utilized every day across major global exchanges to track performance and hedge risk in the financial markets. For more information, visit www.futuresports.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/futuresports-launches-as-new-index-provider-transforming-sports-statistics-into-tradable-financial-instruments-302832829.html

SOURCE FutureSports

Continue Reading

Technology

Capital Group Canada Launches Three Active Equity ETFs on TSX

Published

on

By

The ETF suite now includes five active equity ETFs and two active fixed income ETFs designed to sit at the core of investment portfolios

TORONTO, July 23, 2026 /CNW/ — Capital International Asset Management (Canada), Inc. (“Capital Group Canada”) has launched three new active exchange-traded funds (ETFs) that begin trading on the Toronto Stock Exchange (TSX) today. The three equity strategies are designed to give options for investors looking to diversify their portfolios with non-domestic exposures including U.S., international and developed market securities.  

The new active ETFs are:

CAPU – Capital Group U.S. Equity Select ETF (Canada): Seeks long-term growth of capital and income through investments primarily in common stocks of U.S. issuers.CAPN – Capital Group International Developed Equity Select ETF (Canada): Seeks to provide prudent growth of capital through investments primarily in equity securities of issuers in developed markets outside North America. CAPQ – Capital Group Global Developed Equity Select ETF (Canada): Seeks to provide prudent growth of capital through investments primarily in equity securities of issuers in developed markets.

“As demand for ETFs continues to grow, our expanded lineup gives investors more ways to access Capital Group’s distinctive active investment approach, including our deep research capabilities and multiple portfolio manager system,” said Rick Headrick, president of Capital Group Canada. “As one of the world’s largest active investment managers with over 90 years of experience, we are able to share the benefits of our global scale and offer competitively priced active ETFs designed to sit at the core of an investor’s portfolio.”

“Clients tell us they are looking beyond borders for opportunities to build diversified portfolios,” said Angela Shim, head of product and development at Capital Group Canada. “The three equity strategies expand Capital Group Canada’s core offerings in U.S., international, and global equities, giving investors flexible solutions that can help them navigate global markets and stay focused on their long-term investment goals.”

The three ETFs closed their initial offering of units on July 22, 2026.

The additions expand Capital Group Canada’s ETF lineup to seven, building on a prior launch of two equity and two fixed income ETFs. Details of Capital Group Canada’s full suite of active ETFs can be found here.

About Capital Group

Capital International Asset Management (Canada), Inc. is part of Capital Group, a global investment management firm originating in Los Angeles, California. As Capital Group approaches its 100th anniversary in 2031, its long-term strategy remains firmly rooted in its mission to improve people’s lives through successful investing. With over 9,000 associates and 34 offices around the world, Capital Group manages US$3.6 trillion in assets for millions of wealth management and institutional clients around the world*.

*As of June 30, 2026.

For more information, visit: www.capitalgroup.com/ca/en

SOURCE Capital Group Canada

Continue Reading

Trending